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type was assessed by measuring retinal nerve fibre layer (RFNL) 
and retinal thickness using non invasive technique of Spectral 
domain-optical coherence tomography.  Retinal thinning was ob-
served in old sGC α1 
-/- mice when compared with age matched 
WT mice but not in age matched young sGC and WT mice. Lon-
gitudinal studies were performed to investigate the impact of 
deficiency of sGC α1 
-/- on intraocular pressure. Central Corneal 
thickness (CCT) and depth of anterior chamber (DAC) were other 
parameters analyzed. DAC was measured using in-vivo ultra-
sound biomicroscopy. No significant difference was found in 
CCT. When intraocular pressure (IOP) was measured which is one 
of the major risk factor of POAG again elevated pressure was ob-
served in sGC β1 old mice comparable to age matched WT. 
Fluorometric technique was utilized to assess the outflow rate 
of aqueous humor which revealed that 57 week old sGC α1 
-/- 
mice has less aqueous humor clearance than the same aged WT. 
Vascular dysfunction in retina was analyzed by measuring reti-
nal arterial diameter by in-vivo laser opthalmoscopy. Further to 
explore the role of sGC in human POAG, association between 
POAG and genes encoding α and β subunits of sGC was studied 
by single nucleotide polymorphism analysis in individuals with 
the disease. 
Implications
The present study has demonstrated that deficiency of sGC α1 
leads to primary open angle glaucoma in old mice and thus 
sGC α1 
-/- mice provide a valuable tool for translational studies 
for POAG. This novel animal model may further be explored to 
deduce the mechanism or signal transduction leading to POAG. 
Genetic analysis studies revealed the relevance of this mouse 
model in case of humans. It can also be concluded from the 
present study that sGC is a potential target enzyme to be ex-
ploited for POAG therapeutics.
doi : 10.5214/ans.0972.7531.200207
Background
Glaucoma is an optic neuropathy characterized by retinal gan-
glion cell degeneration leading to vision loss. Primary open 
angle glaucoma is a subtype of glaucoma that results in vi-
sual field loss due to optic nerve damage caused by increase in 
intraocular pressure. Events in primary open angle glaucoma 
(POAG) pathogenesis has been associated with nitric oxide 
(NO) which activates the soluble guanylate cyclase (sGC), a het-
erodimeric enzyme consisting of α and β subunits by c GMP sig-
naling.1,2  In POAG patients NO metabolites and level of c GMP 
has been found to be decreased in aqueous humor. Impaired 
signaling can be a contributing risk factor to the etiology of the 
POAG.3 However whether signal impairment can result in POAG 
and mechanism underlying is yet to be elucidated.
In the present work authors have identified a novel murine 
model to study the pathogenesis of age related optic neurop-
athy in POAG. Further study was extended to human subjects 
to explore the role of sGC in POAG pathophysiology in case of 
humans by performing gene association studies.
Study Design
1 to 17 months old mice deficient in sGC α1 
-/- and age matched 
wild type mice were studied for POAG disease development. Fe-
male mice were studied to rule out the systemic hypertension 
that may give confounding effects. To determine the localization 
of sGC α1 
-/- and β1 subunits immunohistochemical studies were 
carried in mice retinal sections as well as sections of human eyes 
obtained from New England Eye Bank.  sGC α1  and sGC β1 were 
found to be expressed abundantly at three major site ciliary mus-
cles, smooth muscles of retinal vessels and retinal ganglion cells. 
The expression in these sites suggested that sGC might change 
contractibility of ciliary muscles, regulates blood flow or viability 
of RGC that ultimately lead to the disease. Retinal damage in 
young and old sGC α1 
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